top of page
Corporate Securities

Symbol:

PRICE: $00.00

DIVIDEND: $.00

CHANGE: 0.00%

FINANCIAL INFO

Aoxing BioPharmaceutical is an emerging leader in the wellness and care sector.

​

AOXING BIOPHARMACEUTICAL empowers consumers, investors and institutions of all kinds with wellness, care, and rejuvenation products, programs, and services that help people feel their best every day. Our family of brands creates a unique portfolio of products and services.

​

Helping people feel their best is our passion; it drives us to collaborate, develop, and research products and programs that help our clients achieve sustainable and consistent results. Whether you are refreshing your daily routine, exploring new wellness and care options, or building a healthier lifestyle for yourself and your family, our innovative products and services provide the solutions you need to feel your best every day.

Symbol:

PRICE: $00.00

DIVIDEND: $.00

CHANGE: 0.00%

FINANCIAL INFO

Aoxing BioPharmaceutical is an emerging leader in the wellness and care sector.

​

AOXING BIOPHARMACEUTICAL empowers consumers, investors and institutions of all kinds with wellness, care, and rejuvenation products, programs, and services that help people feel their best every day. Our family of brands creates a unique portfolio of products and services.

​

Helping people feel their best is our passion; it drives us to collaborate, develop, and research products and programs that help our clients achieve sustainable and consistent results. Whether you are refreshing your daily routine, exploring new wellness and care options, or building a healthier lifestyle for yourself and your family, our innovative products and services provide the solutions you need to feel your best every day.

NAME

TICKER

CUSIP

DIVIDEND

LIQUIDATION

AMOUNT

OUTSTANDING

($millions)

ISSUE DATE

MATURITY DATE

Fixed Rate / Floating Rate Perpetual Preferred Stock, Series A

-

00000N000

Fixed Rate /

Floating Rate Perpetual

Preferred Stock, Series A

$000

N/A

N/A

Feb. 15

May. 15

Aug. 15

Nov. 15

Who We Are

Investor

relations

GET IN TOUCH

CONTACT INFORMATION

bottom of page